Evaluating Heart & Soil's Lifeblood on Iron and Energy Levels
NCT ID: NCT07293117
Last Updated: 2025-12-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2025-09-09
2026-09-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of this study is to empower participants with personalized data and insights regarding their iron and energy levels. Through the evaluation of a comprehensive iron panel conducted before and after the supplementation of Lifeblood, investigators intend to establish a correlation between these iron levels and the perceptions of energy and fatigue, as reported through supplementary survey data. This approach transcends the realm of generic claims, delving into tangible, real-world outcomes that are directly influenced by participant engagement.
The specific aim is to quantify the impact of Lifeblood supplementation on iron levels and the subsequent enhancement of energy levels, thereby providing participants with personalized health insights. This will not only offer tailored feedback on how the supplement influences individual vitality but will also empower participants with the knowledge to make informed lifestyle decisions based on their unique health profiles.
The significance of this study lies in its potential to revolutionize the way individuals perceive and manage their energy levels through the consumption of natural, whole food, organ extracts. By integrating clinical studies with scientific rigor, investigators are set to validate the real-world experiences of individuals using supplementation to support their health. Although individual results may vary, the anticipated outcome is a personalized understanding of the role of iron in energy maintenance, presenting participants with a navigational tool for future wellness decisions. This study represents a pivotal step towards elevating our understanding of natural health products and their potential to enrich human health and vitality.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single arm where participants act as their own control
Single Arm observational where participants act as their own control
Heart & Soil Lifeblood
Lifeblood is an iron and blood-supporting supplement made of liver, spleen, and whole blood extract.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Heart & Soil Lifeblood
Lifeblood is an iron and blood-supporting supplement made of liver, spleen, and whole blood extract.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* US resident.
* Willing and able to follow the requirements of the protocol.
Exclusion Criteria
* Individuals with Severe Allergies
* Pregnant or Nursing Women
* Individuals with Gastrointestinal Disorders
* Individuals on Iron-Related Medications
* Individuals with Mental Health Disorders
* Competitive Athletes
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Efforia, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Efforia
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Matthew Amsden
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
Additional information and join instructions on Efforia
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
40434
Identifier Type: -
Identifier Source: org_study_id